| 来源类型 | Article |
| 规范类型 | 其他 |
| DOI | 10.1080/13662716.2012.649057 |
| ISBN | 1366-2716 |
| Innovation and firm growth: is R&D worth it? | |
| Demirel, Pelin; Mazzucato, Mariana | |
| 发表日期 | 2012 |
| 出处 | Industry and Innovation |
| 出版者 | Taylor & Francis |
| 出版年 | 2012 |
| 页码 | 45-62 |
| 语种 | 英语 |
| 摘要 | The paper contributes to an emerging literature that critically questions the degree to which R&D, at the centre of national and transnational innovation policies, results in firm growth. The differences in how innovation affects firm growth is explored for small and large publicly quoted US pharmaceutical firms between 1950 and 2008. We observe that the positive impact of R&D on firm growth is highly conditional upon a combination of firm-specific characteristics such as firm size, patenting and persistence in patenting. For small firms, R&D boosts growth for only a subset of firms: namely, those that patent persistently for a minimum of five years. For large pharmaceutical firms, on the other hand, R&D may have a negative impact on growth; potentially resulting from the low R&D productivity these firms have suffered from since the mid-1990s. These results raise important issues around the R&D and firm growth relationship for small and large firms as well the role of persistence in innovation for boosting firm performance |
| URL | http://sro.sussex.ac.uk/id/eprint/20357/ |
| 来源智库 | Science Policy Research Unit (United Kingdom) |
| 引用统计 | |
| 资源类型 | 智库出版物 |
| 条目标识符 | http://119.78.100.153/handle/2XGU8XDN/466664 |
| 推荐引用方式 GB/T 7714 | Demirel, Pelin,Mazzucato, Mariana. Innovation and firm growth: is R&D worth it?. 2012. |
| 条目包含的文件 | 条目无相关文件。 | |||||
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
